---
title: "Barclays Sticks to Its Sell Rating for Dexcom (DXCM)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286694769.md"
description: "Barclays analyst Matt Miksic has maintained a Sell rating on Dexcom (DXCM) as of May 15, with a price target of $64.00. Dexcom's shares closed at $61.63. Miksic, a 2-star analyst, has an average return of 0.6% and a 47.60% success rate. The consensus on Dexcom is a Strong Buy, with an average price target of $79.94."
datetime: "2026-05-18T01:25:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286694769.md)
  - [en](https://longbridge.com/en/news/286694769.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286694769.md)
---

# Barclays Sticks to Its Sell Rating for Dexcom (DXCM)

Barclays analyst Matt Miksic maintained a Sell rating on Dexcom on May 15 and set a price target of $64.00. The company’s shares closed last Friday at $61.63.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Miksic is a 2-star analyst with an average return of 0.6% and a 47.60% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Becton Dickinson, and Boston Scientific.

Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $79.94.

### Related Stocks

- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [BDX.US](https://longbridge.com/en/quote/BDX.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany | DXCM Stock News](https://longbridge.com/en/news/286763500.md)
- [Are Wall Street Analysts Bullish on DexCom’s Stock?](https://longbridge.com/en/news/286558977.md)
- [DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day](https://longbridge.com/en/news/286646080.md)
- [Dexcom Unveils 2030 Targets and $1 Billion Buyback](https://longbridge.com/en/news/286549422.md)
- [BUZZ-Dexcom climbs on plans to revamp board panel](https://longbridge.com/en/news/286583878.md)